| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,586.00
|
|
Change (%)
|
12.75 (0.81%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,554.55
-
1,626.75
|
|
52-Week Range (RS)
|
631.32
-
2,178.47
|
|
Beta (1 Year)
|
-0.04
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Novartis India reports standalone net loss of Rs 77.54 crore in the September 2026 quarter |
| Novartis India to convene board meeting |
| Novartis India announces board meeting date |
| Novartis India to convene board meeting |
| Novartis India Ltd leads gainers in 'B' group |
| Novartis enters into exclusive promotion and distribution agreement with Novartis Healthcare |
| Novartis India to hold AGM |
| Novartis India Ltd Slides 2.56% |
| Novartis India standalone net profit rises 16.62% in the June 2026 quarter |
| Novartis India to announce Quarterly Result |
|
|
|
| Incoporation Year : 1947 |
| Chairman : C Snook |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Evonile Pharma Ltd
The Inspire BKC Part 601 & 701,
Bandra Kurla Complex Bandra(E),
Mumbai,
Maharashtra-400051 |
Phone:91-022-50243000
Fax:91-022-50243010 |
| E-Mail : india.investors@novartis.com |
| URL : http://www.novartis.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
04-Nov-2026 |
1461.80 |
7.62 |
| 1Month |
12-Oct-2026 |
1694.76 |
-7.17 |
| 3Month |
11-Aug-2026 |
1337.47 |
17.63 |
| 6Month |
11-May-2026 |
995.76 |
57.99 |
| 1Year |
11-Nov-2025 |
694.24 |
126.61 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Pharma and Healthcare Fund |
0.46 |
17.03 |
| WhiteOak Capital Pharma and Healthcare.. |
0.24 |
2.25 |
| SBI Healthcare Opportunities Fund |
0.03 |
2.06 |
| Bandhan Healthcare Fund |
0.23 |
0.75 |
| Motilal Oswal BSE Healthcare ETF |
0.08 |
0.03 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
26,503.00 |
1.54 |
30,598.00 |
24,670.10 |
55,462.93 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,657.00 |
-2.55 |
3,121.10 |
2,088.00 |
46,186.86 |
| Pfizer Ltd |
3,865.00 |
-0.73 |
5,329.05 |
3,590.00 |
17,811.42 |
| Astrazeneca Pharma India Ltd |
6,440.30 |
-1.09 |
9,449.00 |
5,660.00 |
16,277.75 |
| Procter & Gamble Health Ltd |
5,772.00 |
-0.45 |
6,955.00 |
4,699.70 |
9,624.16 |
|
|
|
|